Læknablaðið - 15.11.2011, Blaðsíða 30

RANNSÓKN
Heimildir
1. Shi S, Morike K, Klotz U. The clinical implications of
ageing for rational drug therapy. Eur J Clin Pharmacol
2008; 64:183-99.
2. Fialova D, Onder G. Medication errors in elderly people:
contributing factors and future perspectives. Brit J Clin
Pharmacol 2009; 67: 641-5.
3. United Nations. World Population Ageing 2009. United
Nations, New York 2009.
4. Brekke M, Rognstad S, Straand J, et al. Pharmacologically
inappropriate prescriptions for elderly patients in
general practice: How common? Baseline data from The
Prescription Peer Academic Detailing (Rx-PAD) study.
Scand J Prim Health Care 2008; 26:80-5.
5. Crome P. What's different about older people. Toxicology
2003; 192:49-54.
6. Straand J, Fetveit A, Rognstad S, Gjelstad S, Brekke M,
Dalen I. A cluster-randomized educational intervention
to reduce inappropriate prescription pattems for elderly
patients in general practice - The Prescription Peer
Academic Detailing (Rx-PAD) study [NCT00281450].
BMC Health Serv Res 2006; 6: 72.
7. Heimisdóttir M. Mælingar á gæðum. Læknablaðið 2005;
91:44.
8. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR,
Beers MH. Updating the beers criteria for potentially
inappropriate medication use in older adults - Results of
a US consensus panel of experts. Arch Int Med 2003; 163:
2716-24.
9. Gallagher P, Ryan C, Byme S, Kennedy J, O'Mahony D.
STOPP (Screening Tool of Older Person's Prescriptions)
and START (Screening Tool to Alert Doctors to Right
Treatment). Consensus validation. Int J Clin Pharmacol
Ther 2008; 46:72-83.
10. Spinewine A, Schmader KE, Barber N, et al. Prescribing
in elderly people 1 - Appropriate prescribing in elderly
people: how well can it be measured and optimised?
Lancet 2007; 370:173-84.
11. Page RL, Linnebur SA, Bryant LL, Ruscin JM.
Inappropriate prescribing in the hospitalized elderly
patient: Defining the problem, evaluation tools, and
possible solutions. Clin Interv Aging 2010; 5: 75-87.
12. Roth MT, Weinberger M, Campbell WH. Measuring the
Quality of Medication Use in Older Adults. J Am Geriatr
Soc 2009; 57:1096-102.
13. Levy HB, Marcus EL, Christen C. Beyond the beers
criteria: a comparative Overview of Explicit Criteria. Ann
Pharmacother 2010; 44:1968-75.
14. Beers MH, Ouslander JG, Rollingher I, Reuben DB,
Brooks J, Beck JC. Explicit criteria for for determining
inappropriate medication use in nursing-home residents.
Arch Intern Med 1991; 151:1825-32.
15. Straand J, Rokstad KS. Elderly patients in general practice:
diagnoses, drugs and inappropriate prescriptions. A
report from the More & Romsdal Prescription Study. Fam
Pract 1999; 16: 380-8.
16. Aparasu RR, Mort JR. Inappropriate prescribing for the
elderly: Beers criteria-based review. Ann Pharmacother
2000; 34: 338-46.
17. Gurwitz JH. The age/gender interface in geriatric
pharmacotherapy. J Womens Health 2005; 14: 68-72.
18. Johnell K, Fastbom J, Rosen M, Leimanis A. Inappropriate
drug use in the elderly: a nationwide register-based study.
Ann Pharmacother 2007; 41:1243-8.
19. Johnell K, Weitoft GR, Fastbom J. Sex Differences in
Inappropriate Drug Use: a Register-Based Study of Over
600,000 Older People. Ann Pharmacother 2009; 43:1233-8.
20. Helgason T, Tómasson K, Zoéga T. Algengi og dreifing
notkunar geðdeyfðar-, kvíða- og svefnlyfja. Læknablaðið
2003; 89:15-22.
21. Bertakis KD. The influence of gender on the doctor-patient
interaction. Patient Educ Counsel 2009; 76: 356-60.
22. Þengilsdóttir G. Lyf sem orsök innlagna - vísbendingar
í sjúkraskrám [meistaraprófsritgerð]. Lyfjafræðideild
Háskóla íslands, 2009.
23. Samúelsson S, Bjömsson S, Jóhannesson BH, Jónsson PV.
Lyfjanotkun aldraðra á bráðasjúkrahúsi - Aukaverkanir og
gæðavísar. Læknablaðið 2000; 86:11-6.
24. Samúelsson S, Zoéga H, Guðmundsson A, Halldórsson M.
Algengi geðlyfjanotkunar eldri íslendinga utan stofnana.
Læknablaðið 2009; 95:11-7.
25. Ryan C, O'Mahony D, Byme S. Application of STOPP and
START Criteria: Interrater Reliability Among Pharmacists.
Ann Pharmacother 2009; 43:1239-44.
26. Banning M. A review of interventions used to improve
adherence to medication in older people. Int J Nurs
Studies 2009; 46:1505-15.
27. Rochon PA, Gurwitz JH. Prescribing for seniors - Neither
too much nor too little. JAMA 1999; 282:113-5.
ENGLISH SUMMARY
Quality indicators of drug therapy at hospital admission among elderly patients
Sigurðardóttir MS, Guðmundsson A, Guðmundsdóttir ÞK, Almarsdóttir AB
Objective: Increased morbidity and higher prevalence of medication use commonly coexists among the elderly. When managed appropriately, older
patients can benefit from drug therapy. However, drug related problems are more frequent and more serious in the elderly. The aim of the study was to
assess the quality of medication use in older people at hospital admission.
Material and methods: A retrospective medical record review was performed for patients 70 years and older who had an unplanned admission to
the internal medicine and geriatric units at Landspitali University Hospital in 2007. Among the sampled medical records, 913 met inclusion criteria.
Assessment was carried out using 15 drug-specific quality indicators.
Results: Mean age was 80.9 years and 54.5% were women. Mean number of drugs at admission was 7.0 for women and 6.5 for men (p=0.047). The
prevalence of having one or more quality indicators on admission was 48.4%. Women were more likely to have a quality indicator than men (women
56.2%, men 39.9%). The probability also increased with increasing age and number of drugs.
Conclusions: The quality of drug therapy among older patients at hospital admission appears to be suboptimal. A more accurate estimate of the problem
could be obtained through a prospective study where drug regimens are correlated with symptoms and reason for admission. Additional studies are
also needed in the outpatient setting. Such studies could provide more accurate evidence and assist policy making towards improved quality of drug
prescribing for a growing number of older patients.
Keywords: elderly, quality indicators, hospitalization, drugs, inappropriate prescribing.
Correspondence: Anna Birna Almarsdóttir, annaba@hi.is
610 LÆKNAblaðið 2011/97